investorscraft@gmail.com

Intrinsic value of McKesson Corporation (MCK)

Previous Close$379.72
Intrinsic Value
Upside potential
Previous Close
$379.72

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh161.26 

The original valuation is based on fiscal year data as of 2022-03-31 and quarterly data as of 2022-09-30.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2022(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %10.8NaN
Revenue, $263966NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m261928NaN
Operating income, $m2038NaN
EBITDA, $m3039NaN
Interest expense (income), $mNaN
Earnings before tax, $m1750NaN
Tax expense, $m636NaN
Net income, $m1114NaN

BALANCE SHEET

Cash and short-term investments, $m3935NaN
Total assets, $m63298NaN
Adjusted assets (=assets-cash), $m59363NaN
Average production assets, $m16518NaN
Working capital, $m-2235NaN
Total debt, $m7542NaN
Total liabilities, $m65570NaN
Total equity, $m-2272NaN
Debt-to-equity ratio-3.320NaN
Adjusted equity ratio-0.086NaN

CASH FLOW

Net income, $m1114NaN
Depreciation, amort., depletion, $m1001NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m4790NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-535NaN
Free cash flow, $m5325NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m-2235
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount